Network Pharmacology-Based Study on the Mechanism of Bushen-Jianpi Decoction in Liver Cancer Treatment

Table 2

Multivariate analysis of 71 patients with hepatic carcinoma.

Characteristics	Multivariate analysis
	N (%)	B	β	Exp; (β)	95%; CI for; Exp(B)	P-value
Gender		-	-	-	-	0.53
male	63 (88.7)
female	8 (11.3)
Age		-	-	-	-	0.768
≥50	47 (66.2)
< 50	24 (33.8)
Clinical stage composition		2.756	0.696	2.006	1.165-3.455	0.012
I-III	31 (43.7)
IV	40 (56.3)
Serum IL10 levels		-	-	-	-	0.843
> 23.35 pg/mL	43 (60.6)
< 23.35 pg/mL	18 (25.4)
Serum IL12-P40 levels		-	-	-	-	0.335
> 200 ng/L	63 (88.7)
< 200 ng/L	8 (11.3)
Serum IFN-γ levels		-	-	-	-	0.214
> 15 μg/L	53 (74.6)
< 15 μg/L	18 (25.4)
BSJPD		3.258	- 0.567	0.567	0.337-0.954	0.032
yes	35 (49.3)
no	36 (50.7)

Notes. BSJPD, Bushen-Jianpi decoction; IL, interleukin; IFN-γ, interferon-γ; TACE, transcatheter arterial chemoembolization.